CVSNYSEHealthcare
CVS Health (CVS) seasonality
CVS Health Corporation (CVS) seasonality: across 53 complete years (1973–2025), CVS's strongest month has been March (average +3.3%, higher in 34 of 53 years) and its weakest October (average −1.1%, higher in 25 of 53 years). Over the 20 trading sessions after , it rose in 26 of 53 past years, with an average move of −0.5%. Its price has also followed a measurable 7.3-year cycle around its long-term trend. Data through . Historical averages, not a forecast.
Historical averages from daily closing prices, not a forecast and not investment advice. Disclaimer · Methodology
CVS seasonality at a glance
| Month | Average | Median | Years higher | Best year | Worst year |
|---|---|---|---|---|---|
| January | +2.6% | +0.5% | 28 of 53 (53%) | +57.5% (1975) | −12.5% (2000) |
| February | +1.5% | +2.1% | 30 of 53 (57%) | +18.7% (1987) | −13.9% (2018) |
| March Best | +3.3% | +3.1% | 34 of 53 (64%) | +42.9% (1975) | −17.4% (1974) |
| April | +1.0% | +0.4% | 27 of 53 (51%) | +15.8% (2000) | −15.1% (2024) |
| May | +0.4% | 0.0% | 25 of 53 (47%) | +15.0% (1986) | −16.4% (1977) |
| June | +0.2% | −0.1% | 26 of 53 (49%) | +16.5% (1977) | −29.7% (2001) |
| July | +1.0% | +0.7% | 27 of 53 (51%) | +17.9% (1973) | −13.0% (1986) |
| August | +0.5% | +0.7% | 29 of 53 (55%) | +17.8% (2025) | −20.6% (1990) |
| September | −0.1% | −1.2% | 22 of 53 (42%) | +24.8% (2000) | −15.7% (1974) |
| October Worst | −1.1% | −1.2% | 25 of 53 (47%) | +16.5% (1975) | −28.0% (1987) |
| November Now | +0.9% | +0.2% | 27 of 53 (51%) | +20.9% (2020) | −36.4% (1973) |
| December | +0.8% | +0.7% | 29 of 53 (55%) | +17.6% (1974) | −25.0% (2024) |
Current seasonal picture · November 13, 2026
As of November 13, 2026, CVS Health Corporation is +12.6% year to date. Across 53 complete years (1973–2025), the average at this point of the year was +11.8%, so CVS is running ahead of its seasonal average by 0.7 percentage points. A year ago on the same date it was +76.5% year to date.
Over the next 20 trading days (about four weeks) from this date, CVS historically averaged −0.5% (median 0.0%) and rose in 26 of 53 years (49%). Best: +16.5% in 1998; worst: −37.3% in 1973. For comparison, SPY (the S&P 500) averaged +1.3% over the same window, up in 23 of 32 years, so CVS's seasonal edge over the market for this window is −1.8%.
In the last 20 sessions, CVS moved in the same direction as its seasonal average on 7 of 20 days (35%), less often than the 50% you would expect by chance, a sign that other forces are dominating right now.
Within the next 60 days, the historically strongest 10-session window began around December 20 (average +3.4%, up in 40 of 53 years) and the weakest around December 4 (average −1.5%, up in 22 of 53 years).
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Next trading week (Monday to Friday): will CVS close up, flat or down?
A free poll for fun and research: no stakes, no prizes, not advice. One vote per person per week; you can change it until the week starts. Results are scored from closing prices after the week ends. All results · My calls
CVS seasonal charts
Seasonality by calendar date
Each line is one calendar year of CVS Health Corporation, measured as its return since the previous year's final close (year to date) and drawn on a common January-to-December axis. The bold average line shows where CVS has typically stood on each date across every complete year on file.
How the average is built. Returns are compounded from daily closing prices. Every year counts on every date: on weekends and market holidays a year keeps its last close, so the average is never built from a different mix of years on different days. Only complete calendar years enter the average, so a partial current year or a mid-year listing cannot distort it. This view surfaces date-anchored effects such as tax-loss selling into December, the January effect, quarter-end rebalancing and recurring earnings seasons.
Day-of-year seasonality for CVS
The bold blue line is the multi-year average and orange is the current year; thinner coloured lines are the most recent years, and older years appear in grey when you choose All years. When the current-year line sits above the average, CVS is ahead of its usual pace for the date. Hover any point to compare each year with the average on that day.
What the data says now · November 13, 2026
As of November 13, 2026, CVS Health Corporation is +12.6% year to date. Across 53 complete years (1973–2025), the average at this point of the year was +11.8%, so CVS is running ahead of its seasonal average by 0.7 percentage points. A year ago on the same date it was +76.5% year to date.
This year's path so far has a correlation of 0.62 with the seasonal average (1 would be a perfect match, 0 no relationship), so 2026 has broadly followed the typical seasonal shape.
The past years whose path most resembled 2026 up to this date: 2005 (next 20 sessions: +4.5%), 1980 (next 20 sessions: −13.6%), 2004 (next 20 sessions: −2.1%).
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Seasonality by week and weekday
Here each session is placed by its week number and weekday instead of its date. Weeks run Sunday to Saturday and week 1 is the week that contains January 1. Because calendar dates shift by a day or two each year, week numbers line up comparable sessions: week 14 ran from Monday, April 1 to Friday, April 5 in 2024, from March 31 to April 4 in 2025 and from March 30 to April 3 in 2026. Comparing "week 14, Monday" across years therefore compares the first Monday of the second quarter each time, which a fixed date such as April 1 cannot do.
Use this view for weekday tendencies (soft Mondays, strong Fridays) and to see how a pattern drifts week by week through the year. Each point is the year-to-date return at that week and weekday, averaged across complete years.
Year-to-date path by week number and weekday
Each line is one year building through the weeks; the bold line is the average. Where the yearly lines bunch together, the pattern repeated year after year; where they fan out, that stretch of the calendar was driven by events rather than the season. Labels read "week - weekday", for example "14 - Mon".
What the data says now · November 13, 2026
Over the last ten years, CVS's strongest weekday was Friday (average +0.16%, up on 56% of Fridays) and its weakest was Thursday (−0.18%, up on 48%). Differences this small are easily swamped by news, so read them as tendencies, not rules.
For the coming week (the next 5 sessions from November 13, 2026), CVS historically averaged −1.0% and rose in 21 of 53 years.
In the last 8 completed weeks, the weekly move matched the direction of the seasonal average in 3 of 8.
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Seasonality by trading day of the month
Sessions are numbered by their position inside each month: trading day 1 is the first session of the month, day 2 the second, whatever the calendar date. Most months have 19 to 23 sessions. Lining months up this way exposes flow-driven effects that calendar dates blur, such as pension and payroll inflows around the turn of the month, mid-month options expiry and fund rebalancing in the final sessions.
The chart runs from the first trading day of January to the last trading day of December, so each point is the year-to-date return after that session. On the axis, trading day N of a month is drawn at day N of that month.
Year-to-date path by trading day of the month for CVS
Steps that recur at the same point of every month, a rise over the first few sessions or a dip before month-end, are the signature of flows rather than news. Compare the slope of the average around the start and end of each month with the middle weeks.
What the data says now · November 13, 2026
After 10 trading days of November, CVS is −1.0% month to date. At the same point of November in past years it averaged +0.4% (median +0.4%, up in 28 of 53 years).
Turn of the month: over the last ten years, the last two and first three trading days of each month averaged +0.03% per day, versus +0.01% on the other days, the classic month-end inflow pattern.
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
CVS seasonality vs the S&P 500
CVS seasonality compared with the S&P 500 (SPY)
Both lines are average year-to-date returns over the same complete years, so the comparison is like for like. The dashed line is the gap: when it rises, CVS has typically outperformed the market over that stretch of the calendar; when it falls, it has typically lagged. A stock with a strong seasonal line can still trail the market if SPY rises even more in the same weeks.
Measured over the same 32 complete years (1994–2025), CVS's average calendar year ended +11.4% against +10.3% for SPY. The month in which CVS typically gained most on the market was Mar (+1.8% relative), and the month it typically lost most ground was Oct (−1.5%).
Show the numbers
| End of | CVS | SPY | Gap |
|---|---|---|---|
| Jan | −0.1% | +0.7% | −0.8% |
| Feb | +1.1% | +0.9% | +0.2% |
| Mar | +3.5% | +1.4% | +2.1% |
| Apr | +5.2% | +3.2% | +2.0% |
| May | +5.3% | +4.2% | +1.2% |
| Jun | +4.7% | +4.4% | +0.3% |
| Jul | +5.4% | +6.0% | −0.5% |
| Aug | +5.6% | +5.8% | −0.2% |
| Sep | +6.8% | +5.1% | +1.7% |
| Oct | +6.9% | +6.8% | +0.1% |
| Nov | +10.2% | +9.6% | +0.6% |
| Dec | +11.4% | +10.3% | +1.1% |
Calendar date vs week and weekday vs trading day of the month
The averages from methods 1, 2 and 3 above, placed on one calendar axis (week slots and trading days are drawn on the dates they fell on in 2021). Lines that overlap mean the seasonal pattern holds however you count the sessions; a gap shows where an effect depends on the counting, typically around month ends and holidays.
All three methods measure the same thing, the average year-to-date return across 53 complete years, but line the sessions up differently. For CVS they agree closely: the largest gap between them is 1.5 percentage points around October 25. Where the lines separate, the effect depends on how you count (by date, by weekday or by session of the month); where they overlap, the pattern is robust to the method.
Show the numbers
| End of | Calendar date | Week & weekday | Trading day |
|---|---|---|---|
| Jan | +2.6% | +2.4% | +2.5% |
| Feb | +4.3% | +4.5% | +4.3% |
| Mar | +8.2% | +7.9% | +8.2% |
| Apr | +9.1% | +8.6% | +9.1% |
| May | +9.7% | +9.7% | +9.3% |
| Jun | +10.1% | +9.9% | +10.1% |
| Jul | +10.7% | +10.9% | +10.7% |
| Aug | +11.4% | +11.7% | +11.5% |
| Sep | +11.3% | +11.1% | +11.3% |
| Oct | +11.1% | +10.9% | +11.1% |
| Nov | +12.6% | +12.0% | +12.6% |
| Dec | +13.5% | +13.5% | +13.5% |
CVS monthly returns heatmaps
Intraday momentum. Each cell sums the daily open-to-close percent changes inside that month, leaving out the overnight gaps between one close and the next open. Compare it with the next heatmap to see whether a month's gains came during trading hours or overnight. Very old years can show 0.00 where the data source recorded a single price per day.
Held through the month. Each cell is the change from the first session open to the last session close — the return of entering on day one and exiting on the final bar.
CVS earnings, revenue and company events
Earnings reaction history · 89 reports since Nov 2004
On the first trading session after its earnings releases, CVS closed higher 48 of 89 times (54%), with a typical move of ±3.9%. Average reaction by fiscal quarter: Q1 +0.5% (up 15 of 22) · Q2 +0.1% (up 8 of 22) · Q3 −0.2% (up 12 of 23) · Q4 +1.1% (up 13 of 22).
Across 88 reports with full windows, the stock moved −0.0% on average in the 15 sessions before the report and −0.0% in the 15 sessions after the reaction day.
The latest report was released on November 4, 2026 (before the open) for fiscal Q3 2026; the stock moved −12.53% on the reaction day.
Report dates and actual EPS come from the company's SEC filings; price moves from daily closes. Analyst estimates are not shown. Past reactions do not predict the next one. Reports before late 2004 are not included: companies have flagged earnings releases in SEC filings (Form 8-K, Item 2.02) only since August 2004, while CVS's price history goes back to 1972.
Post-earnings price move: the last 12 reports and the average
0 is the first session after the release; each line is the change from the close before it. Thin lines are single reports, coloured by fiscal quarter (solid = latest, dashed = a year earlier, dotted = two years earlier); the thick line is the average of all reports. Use the buttons to switch to averages by quarter, or click any legend item.
| Released | Timing | Fiscal quarter | EPS (diluted) | EPS vs year ago | Reaction day | 15 sessions before | 15 sessions after |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Before open | Q3 2026 | $1.68 | – | −12.53% | +4.4% | – |
| Aug 5, 2026 | Before open | Q2 2026 | $2.31 | +189% | −5.08% | −1.7% | −4.8% |
| May 6, 2026 | Before open | Q1 2026 | $2.30 | +63% | +7.65% | +4.0% | +7.0% |
| Feb 10, 2026 | Before open | Q4 2025 | $2.31* | – | −0.09% | −3.6% | +6.4% |
| Oct 29, 2025 | Before open | Q3 2025 | $-3.13 | −4,571% | −1.95% | +6.6% | −5.0% |
| Jul 31, 2025 | Before open | Q2 2025 | $0.80 | −43% | −0.32% | −6.5% | +15.0% |
| May 1, 2025 | Before open | Q1 2025 | $1.41 | +60% | +4.11% | −1.4% | −13.3% |
| Feb 12, 2025 | Before open | Q4 2024 | $1.30* | – | +14.95% | +3.5% | +3.2% |
| Oct 18, 2024 | Before open | Q3 2024 | $0.07 | −96% | −5.23% | +7.9% | −8.0% |
| Aug 7, 2024 | Before open | Q2 2024 | $1.41 | −5% | −3.21% | −2.9% | +1.4% |
| May 1, 2024 | Before open | Q1 2024 | $0.88 | −47% | −16.84% | −7.7% | +2.0% |
| Feb 7, 2024 | Before open | Q4 2023 | $1.59* | – | +3.10% | −4.7% | −2.2% |
| Nov 1, 2023 | Before open | Q3 2023 | $1.75 | – | −0.41% | −3.8% | +0.6% |
| Aug 2, 2023 | Before open | Q2 2023 | $1.48 | −35% | +3.33% | +3.8% | −13.1% |
| May 3, 2023 | Before open | Q1 2023 | $1.65 | −7% | −3.68% | −4.6% | −1.8% |
| Feb 8, 2023 | Before open | Q4 2022 | $1.89* | – | +3.47% | −3.8% | −8.5% |
| Nov 2, 2022 | Before open | Q3 2022 | $-2.60 | −317% | +2.30% | +6.9% | +3.4% |
| Aug 3, 2022 | Before open | Q2 2022 | $2.23 | +6% | +6.30% | +0.4% | −0.1% |
| May 4, 2022 | Before open | Q1 2022 | $1.74 | +4% | +4.78% | −8.1% | −3.4% |
| Feb 9, 2022 | Before open | Q4 2021 | $1.04* | – | −5.45% | +6.1% | −0.2% |
| Nov 3, 2021 | Before open | Q3 2021 | $1.20 | +29% | +5.69% | +8.8% | −3.8% |
| Aug 4, 2021 | Before open | Q2 2021 | $2.10 | −7% | −2.92% | +2.9% | +2.5% |
| May 4, 2021 | Before open | Q1 2021 | $1.68 | +10% | +4.41% | +4.3% | +9.3% |
| Feb 16, 2021 | Before open | Q4 2020 | $0.74* | – | −4.96% | +0.1% | +1.0% |
| Nov 6, 2020 | Before open | Q3 2020 | $0.93 | −21% | +5.76% | +3.5% | +4.4% |
| Aug 5, 2020 | Before open | Q2 2020 | $2.26 | +52% | −0.89% | +2.0% | −2.6% |
| May 6, 2020 | Before open | Q1 2020 | $1.53 | +40% | −1.31% | −0.6% | +10.2% |
| Feb 12, 2020 | Before open | Q4 2019 | $1.33 | – | −0.14% | −1.0% | −12.7% |
| Nov 6, 2019 | Before open | Q3 2019 | $1.17 | −14% | +5.36% | +3.8% | +5.8% |
| Aug 7, 2019 | Before open | Q2 2019 | $1.49 | – | +7.45% | −5.7% | +2.3% |
| May 1, 2019 | Before open | Q1 2019 | $1.09 | +11% | +5.42% | +0.4% | −6.3% |
| Feb 20, 2019 | Before open | Q4 2018 | $-0.37 | −111% | −8.10% | +7.1% | −11.9% |
| Nov 6, 2018 | Before open | Q3 2018 | $1.36 | +8% | +5.71% | +0.9% | +3.0% |
| Aug 8, 2018 | Before open | Q2 2018 | $-2.52 | −336% | +4.16% | −3.7% | +9.2% |
| May 2, 2018 | Before open | Q1 2018 | $0.98 | +7% | −3.03% | +6.3% | −0.6% |
| Feb 8, 2018 | Before open | Q4 2017 | $3.22 | +103% | −5.11% | −6.5% | −4.4% |
| Nov 6, 2017 | Before open | Q3 2017 | $1.26 | −12% | −3.54% | −4.6% | +8.8% |
| Aug 8, 2017 | Before open | Q2 2017 | $1.07 | +24% | −0.70% | +1.1% | −3.2% |
| May 2, 2017 | Before open | Q1 2017 | $0.92 | −12% | −3.61% | +6.3% | −2.2% |
| Feb 9, 2017 | Before open | Q4 2016 | $1.59 | +19% | +0.36% | −7.8% | +4.8% |
| Nov 8, 2016 | Before open | Q3 2016 | $1.43 | +29% | −11.82% | −3.8% | +4.6% |
| Aug 2, 2016 | Before open | Q2 2016 | $0.86 | −23% | +4.89% | −3.5% | −0.8% |
| May 3, 2016 | Before open | Q1 2016 | $1.04 | −3% | +2.43% | +0.7% | −6.3% |
| Feb 9, 2016 | Before open | Q4 2015 | $1.34 | +18% | +0.96% | −4.5% | +9.0% |
| Oct 30, 2015 | Before open | Q3 2015 | $1.11 | +37% | −4.84% | +1.6% | −6.9% |
| Aug 4, 2015 | Before open | Q2 2015 | $1.12 | +6% | −2.54% | +3.4% | −9.1% |
| May 1, 2015 | Before open | Q1 2015 | $1.07 | +13% | +1.18% | −3.0% | +3.5% |
| Feb 10, 2015 | Before open | Q4 2014 | $1.14 | +9% | +2.13% | +0.8% | +1.4% |
| Nov 4, 2014 | Before open | Q3 2014 | $0.81 | −21% | −0.75% | +7.5% | +5.6% |
| Aug 5, 2014 | Before open | Q2 2014 | $1.06 | +16% | −0.13% | +0.1% | +2.7% |
| May 2, 2014 | Before open | Q1 2014 | $0.95 | +23% | +1.05% | −1.8% | +4.4% |
| Feb 11, 2014 | Before open | Q4 2013 | $1.05 | +17% | +2.73% | −1.5% | +6.4% |
| Nov 5, 2013 | Before open | Q3 2013 | $1.02 | +29% | +2.00% | +3.8% | +4.5% |
| Aug 6, 2013 | Before open | Q2 2013 | $0.91 | +21% | −2.81% | +1.6% | −3.7% |
| May 1, 2013 | Before open | Q1 2013 | $0.77 | +31% | +0.98% | +2.8% | −0.1% |
| Feb 6, 2013 | Before open | Q4 2012 | $0.90 | +11% | −0.93% | −0.3% | −0.2% |
| Nov 6, 2012 | Before open | Q3 2012 | $0.79 | +22% | +0.54% | −2.0% | −2.1% |
| Aug 7, 2012 | Before open | Q2 2012 | $0.75 | +25% | −1.74% | −6.6% | +2.8% |
| May 2, 2012 | Before open | Q1 2012 | $0.59 | +13% | +2.71% | +2.7% | −2.1% |
| Feb 8, 2012 | Before open | Q4 2011 | $0.81 | +8% | +1.14% | +1.3% | +3.8% |
| Nov 3, 2011 | Before open | Q3 2011 | $0.65 | +10% | +4.31% | +3.2% | −1.2% |
| Aug 4, 2011 | Before open | Q2 2011 | $0.60 | 0% | −6.10% | −2.9% | −0.1% |
| May 5, 2011 | Before open | Q1 2011 | $0.52 | −5% | +1.85% | +0.0% | +3.7% |
| Feb 3, 2011 | Before open | Q4 2010 | $0.75 | +1% | −4.99% | −1.9% | +0.1% |
| Nov 3, 2010 | Before open | Q3 2010 | $0.59 | −17% | +1.11% | −1.4% | +2.2% |
| Jul 28, 2010 | Before open | Q2 2010 | $0.60 | 0% | +3.07% | +7.2% | −7.9% |
| May 4, 2010 | Before open | Q1 2010 | $0.55 | +10% | −1.62% | +0.3% | −6.6% |
| Feb 8, 2010 | Before open | Q4 2009 | $0.74 | – | +5.31% | −8.5% | +5.9% |
| Nov 5, 2009 | Before open | Q3 2009 | $0.71 | +42% | −20.14% | −3.4% | +8.1% |
| Aug 4, 2009 | Before open | Q2 2009 | $0.60 | +13% | −0.06% | +7.3% | +8.6% |
| May 5, 2009 | Before open | Q1 2009 | $0.50 | – | −0.72% | +7.1% | −8.8% |
| Feb 19, 2009 | Before open | Q4 2008 | – | – | +6.37% | −2.2% | −9.0% |
| Oct 30, 2008 | Intraday | Q3 2008 | $0.50 | – | +11.44% | −11.8% | −8.6% |
| Jul 31, 2008 | Before open | Q2 2008 | $0.53 | – | −5.37% | 0.0% | +2.4% |
| May 1, 2008 | Before open | Q1 2008 | – | – | +1.04% | −0.5% | +4.4% |
| Jan 31, 2008 | Before open | Q4 2007 | – | – | +8.02% | −4.0% | +3.2% |
| Nov 1, 2007 | Before open | Q3 2007 | – | – | −1.51% | +7.2% | +2.2% |
| Aug 2, 2007 | Before open | Q2 2007 | – | – | +3.52% | −1.8% | +0.1% |
| May 8, 2007 | Before open | Q1 2007 | – | – | +2.46% | +3.4% | +5.0% |
| Feb 1, 2007 | Before open | Q4 2006 | – | – | −1.07% | +8.5% | −2.4% |
| Nov 1, 2006 | After close | Q3 2006 | – | – | −0.69% | −6.7% | −3.1% |
| Aug 3, 2006 | Before open | Q2 2006 | – | – | +2.14% | +3.7% | −3.0% |
| May 4, 2006 | Before open | Q1 2006 | – | – | +0.93% | −1.0% | −5.2% |
| Feb 2, 2006 | Before open | Q4 2005 | – | – | +3.35% | +2.4% | −1.7% |
| Nov 3, 2005 | Before open | Q3 2005 | – | – | +7.96% | −1.1% | +5.8% |
| Aug 3, 2005 | Before open | Q2 2005 | – | – | −1.54% | +1.1% | −6.6% |
| May 5, 2005 | Before open | Q1 2005 | – | – | +0.97% | +2.2% | +2.0% |
| Feb 2, 2005 | Before open | Q4 2004 | – | – | +3.70% | +1.1% | +2.4% |
| Nov 4, 2004 | Before open | Q3 2004 | – | – | +5.68% | +3.8% | −2.5% |
* Q4 EPS derived from the annual figure minus the first three quarters. EPS as reported by the company; not adjusted for later stock splits.
Where the revenue comes from · as reported to the SEC
CVS reports its revenue by 5 business segments. Latest: $108B in the quarter ending Sep 2026, +5% from a year earlier.
Figures are from CVS’s own 10-Q and 10-K financial statements (XBRL), as reported, not adjusted. Products, segments and regions are the company’s own groupings and can change when it reorganises; only periods comparable with the latest are shown. * Fourth quarter = fiscal year minus the first nine months.
CVS revenue by business segment
In the quarter ending Sep 2026, Health Services brought in $54.0B, 50% of CVS’s $108B revenue. Compared with a year earlier, Health Services grew fastest (+10%) and Pharmacy & Consumer Wellness shrank most (−2%).
| Quarter ending | Dec ’24* | Mar ’25 | Jun ’25 | Sep ’25 | Dec ’25* | Mar ’26 | Jun ’26 | Sep ’26 | Share | vs year before |
|---|---|---|---|---|---|---|---|---|---|---|
| Health Services | $47.0B | $43.5B | $46.5B | $49.3B | $51.2B | $48.2B | $51.8B | $54.0B | 50% | +10% |
| Health Care Benefits | $33.0B | $34.8B | $36.3B | $36.0B | $36.3B | $36.0B | $37.5B | $36.9B | 34% | +2% |
| Pharmacy & Consumer Wellness | $33.5B | $31.9B | $33.6B | $36.2B | $37.7B | $32.0B | $33.8B | $35.5B | 33% | −2% |
| Corporate/ Other | $83M | $133M | $96M | $133M | $122M | $126M | $147M | $205M | 0% | +54% |
| Intersegment eliminations | −$15.9B | −$15.7B | −$17.5B | −$18.7B | −$19.6B | −$15.9B | −$17.2B | −$18.1B | −17% | — |
| Total revenue | $97.7B | $94.6B | $98.9B | $103B | $106B | $100B | $106B | $108B | 100% | +5% |
Fiscal years
| Fiscal year ending | Dec ’22 | Dec ’23 | Dec ’24 | Dec ’25 | Share | vs year before |
|---|---|---|---|---|---|---|
| Health Services | $170B | $187B | $174B | $190B | 47% | +10% |
| Health Care Benefits | $91.4B | $106B | $131B | $143B | 36% | +10% |
| Pharmacy & Consumer Wellness | $109B | $117B | $125B | $139B | 35% | +12% |
| Corporate/ Other | $530M | $451M | $451M | $484M | 0% | +7% |
| Intersegment eliminations | −$47.6B | −$51.9B | −$56.4B | −$71.6B | −18% | — |
| Total revenue | $322B | $358B | $373B | $402B | 100% | +8% |
Company events · from 252 SEC 8-K filings since 2004
In the last five years CVS filed 64 event reports, including 1 major events, 3 deals, 1 restructuring & write-downs, 13 leadership, 4 results updates. On the days after major events (deals completed, restructurings, write-downs and similar) the stock moved 3.2% on average in either direction, against 1.3% on a typical day. Latest major event: debt acceleration or default on May 2, 2023 (−3.7% the next session).
From the item codes companies must use when filing a Form 8-K with the SEC. Under each event type is a one-line extract of what the filing says, picked out of the filing text automatically (not written or checked by an editor); open the filing for the full wording. Quarterly earnings releases are in the section above.
| Filed | Event | Next-session move | Source |
|---|---|---|---|
| Investor presentation or announcementAnnounced its intention to separate into two independent, publicly traded companies in a transaction that is intended to be tax-free to the Company and its shareholders for U.S. federal income tax purposes. | −12.53% | SEC filing | |
| Executive or board change · Investor presentation or announcementLarry M. Robbins notified the Board of Directors of CVS Health Corporation of his resignation from the Board, effective immediately. | +0.96% | SEC filing | |
| Executive or board change · Shareholder vote resultsAt the Annual Meeting, the Company’s stockholders approved the 2026 Incentive Compensation Plan of CVS Health Corporation, which replaces the Company’s expiring 2017 Incentive Compensation Plan. | −1.89% | SEC filing | |
| Executive or board changeThe Board of Directors of CVS Health Corporation elected John E. Gallina to serve on the Board, effective March 19, 2026. | −0.53% | SEC filing | |
| Investor presentation or announcementIn connection with its 2025 Investor Day, on December 9, 2025, CVS Health Corporation issued a press release that, among other things, discussed its strategic priorities, updated its 2025 full-year financial guidance and provided its… | +2.23% | SEC filing | |
| Other company newsThe Board of Directors of CVS Health Corporation appointed J. David Joyner, President and Chief Executive Officer of the Company, to the additional role of Chair of the Board, effective January 1, 2026. | +2.62% | SEC filing | |
| Other company newsAnnounced that Omnicare and certain of its subsidiary entities have voluntarily initiated chapter 11 proceedings under the U.S. Bankruptcy Code, in order to resolve issues related to its recent litigation in the U.S. District Court for… | +1.82% | SEC filing | |
| Other company newsCVS Health Corporation entered into an Underwriting Agreement with Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the several underwriters named in Schedule I thereto, pursuant to… | +2.29% | SEC filing | |
| Shareholder vote resultsThe following are the voting results on each matter submitted to the stockholders of CVS Health Corporation at the Annual Meeting of Stockholders held on May 15, 2025. | −2.56% | SEC filing | |
| Executive or board change · Investor presentation or announcementThe Board of Directors of CVS Health Corporation appointed Brian O. Newman to serve as Executive Vice President and Chief Financial Officer of CVS Health, effective May 12, 2025. | +5.92% | SEC filing | |
| Other company newsCVS Health Corporation issued press releases announcing the (A) early results and election of early settlement and (B) pricing, respectively, of its cash tender offer for the maximum principal amount of the following series of Maximum… | −5.49% | SEC filing | |
| Other company newsCVS Health Corporation issued and sold $2,250,000,000 aggregate principal amount of the Company’s 7.000% Fixed-to-Fixed Rate Series A Junior Subordinated Notes due 2055 and $750,000,000 aggregate principal amount of the Company’s 6.750%… | −6.15% | SEC filing | |
| Other company newsAnnounced the expiration and tender results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025, in connection with the Company’s previously announced cash tender offers commenced on December 2, 2024. | +1.41% | SEC filing | |
| Other company newsAnnounced the pricing of its cash tender offer for any and all of its 4.100% Senior Notes due 2025, in connection with the Company’s previously announced cash tender offers commenced on December 2, 2024. | +1.41% | SEC filing | |
| Other company newsCVS Health Corporation entered into an Underwriting Agreement with Barclays Capital Inc., Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters named in Schedule I thereto, pursuant to… | −2.05% | SEC filing | |
| Other company newsAnnounced the commencement of cash tender offers for (1) any and all of its 4.100% Senior Notes due 2025, and (2) the maximum principal amount of the following series of notes for which the aggregate purchase price, not including accrued… | −1.29% | SEC filing | |
| Signed a material agreement · Executive or board change · Investor presentation or announcementCVS Health Corporation entered into a confidentiality agreement with Glenview Capital Management, LLC. | +5.38% | SEC filing | |
| Executive or board change · Investor presentation or announcementCVS Health Corporation appointed Prem S. Shah as Executive Vice President and Group President, a newly created position within the Company. | +11.33% | SEC filing | |
| Results updateAnnounced results for the three months ended September 30, 2024. | +11.33% | SEC filing | |
| Executive or board change · Shareholder vote resultsCVS Health Corporation held its 2024 Annual Meeting of Stockholders. At the Annual Meeting, the Company’s stockholders approved amendments to the 2017 Incentive Compensation Plan of CVS Health Corporation, principally to increase the… | −3.12% | SEC filing | |
| Other company newsCVS Health Corporation issued and sold $1,000,000,000 aggregate principal amount of the Company’s 5.400% Senior Notes due 2029, $1,000,000,000 aggregate principal amount of the Company’s 5.550% Senior Notes due 2031, $1,250,000,000… | +0.25% | SEC filing | |
| Other company newsCVS Health Corporation entered into an Underwriting Agreement with BofA Securities, Inc., Barclays Capital Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the several… | +1.40% | SEC filing | |
| Investor presentation or announcementMembers of CVS Health Corporation’s senior management team will meet with investors and Executive Vice President and Chief Financial Officer Tom Cowhey will participate in a webcast at 9:50 a.m. | −0.24% | SEC filing | |
| Results update · Executive or board change · Investor presentation or announcementMembers of the senior management team of CVS Health Corporation will meet with investors and will participate in a webcast at 10:30 a.m. | +1.13% | SEC filing | |
| Investor presentation or announcementIn connection with its 2023 Investor Day, on December 5, 2023, CVS Health Corporation issued a press release that, among other things, discussed its strategic priorities, reiterated its 2023 financial guidance and initiated 2024 projections. | +3.71% | SEC filing | |
| Executive or board change · Investor presentation or announcement | −0.07% | SEC filing | |
| Investor presentation or announcement | −0.07% | SEC filing | |
| Executive or board change | +0.67% | SEC filing | |
| Investor presentation or announcement | +2.57% | SEC filing | |
| Investor presentation or announcement | +0.14% | SEC filing | |
| Investor presentation or announcement | −8.14% | SEC filing | |
| Executive or board change | +0.24% | SEC filing | |
| Other company news | +1.07% | SEC filing | |
| Other company news | +1.25% | SEC filing | |
| Investor presentation or announcement | +1.31% | SEC filing | |
| Other company news | −1.67% | SEC filing | |
| Shareholder vote results | −1.67% | SEC filing | |
| Debt acceleration or default · Signed a material agreement · New debt or financing · Other company news | −3.68% | SEC filing | |
| Investor presentation or announcement | +0.82% | SEC filing | |
| Other company news | −0.47% | SEC filing | |
| Other company news | −0.43% | SEC filing | |
| Signed a material agreement | +1.25% | SEC filing | |
| Investor presentation or announcement | +3.47% | SEC filing | |
| Executive or board change · Investor presentation or announcement | −1.35% | SEC filing | |
| Results update | −0.12% | SEC filing | |
| Bylaws or fiscal year change · Other company news | +1.65% | SEC filing | |
| Other company news | −0.73% | SEC filing | |
| Other company news | −10.48% | SEC filing | |
| Executive or board change | −2.51% | SEC filing | |
| Investor presentation or announcement | −2.51% | SEC filing | |
| Other company news | −0.71% | SEC filing | |
| Signed a material agreement | −0.71% | SEC filing | |
| Other company news | +6.30% | SEC filing | |
| Other company news | −1.13% | SEC filing | |
| Investor presentation or announcement | −1.21% | SEC filing | |
| Shareholder vote results | +0.84% | SEC filing | |
| Other company news | +0.84% | SEC filing | |
| Other company news | −1.08% | SEC filing | |
| Executive or board change | +0.47% | SEC filing | |
| Executive or board change | +0.46% | SEC filing | |
| Results update | +0.93% | SEC filing | |
| Other company news | −0.12% | SEC filing | |
| Investor presentation or announcement | +4.52% | SEC filing | |
| Impairment (write-down) · Investor presentation or announcement | +2.81% | SEC filing | |
| Other company news | −0.93% | SEC filing | |
| Other company news | −0.43% | SEC filing | |
| Other company news | +0.22% | SEC filing | |
| Other company news | +0.49% | SEC filing | |
| Executive or board change | −0.04% | SEC filing | |
| Executive or board change · Investor presentation or announcement | +4.79% | SEC filing | |
| Shareholder vote results | +4.79% | SEC filing | |
| Other company news | −2.17% | SEC filing | |
| Other company news | +0.39% | SEC filing | |
| Other company news | −1.80% | SEC filing | |
| Other company news | −1.17% | SEC filing | |
| Executive or board change | +3.97% | SEC filing | |
| Investor presentation or announcement | +1.08% | SEC filing | |
| Investor presentation or announcement | −1.67% | SEC filing | |
| Other company news | +1.10% | SEC filing | |
| Other company news | −0.11% | SEC filing | |
| Other company news | −1.17% | SEC filing | |
| Other company news | −0.41% | SEC filing | |
| Bylaws or fiscal year change | −0.05% | SEC filing | |
| Investor presentation or announcement | −2.68% | SEC filing | |
| Shareholder vote results | −0.61% | SEC filing | |
| Other company news | −1.67% | SEC filing | |
| Other company news | +8.71% | SEC filing | |
| Executive or board change | −4.44% | SEC filing | |
| Executive or board change | −0.14% | SEC filing | |
| Executive or board change | +2.36% | SEC filing | |
| Executive or board change · Other company news | −1.31% | SEC filing | |
| Other company news | +1.78% | SEC filing | |
| Executive or board change | +1.28% | SEC filing | |
| Other company news | +0.65% | SEC filing | |
| Other company news | +1.84% | SEC filing | |
| Other company news | +2.45% | SEC filing | |
| Other company news | +0.48% | SEC filing | |
| Other company news | +1.87% | SEC filing | |
| Other company news | +1.58% | SEC filing | |
| Other company news | +1.58% | SEC filing | |
| Investor presentation or announcement | +2.30% | SEC filing | |
| Shareholder vote results | +0.23% | SEC filing | |
| Completed an acquisition or sale of assets · New debt or financing · Executive or board change · Investor presentation or announcement | −0.34% | SEC filing | |
| Other company news | +3.54% | SEC filing | |
| Executive or board change · Investor presentation or announcement · Other company news | −3.86% | SEC filing | |
| Signed a material agreement · New debt or financing | +0.60% | SEC filing | |
| Executive or board change · Investor presentation or announcement | −0.54% | SEC filing | |
| Executive or board change · Investor presentation or announcement | −7.26% | SEC filing | |
| Investor presentation or announcement | −0.72% | SEC filing | |
| Investor presentation or announcement | +0.42% | SEC filing | |
| Investor presentation or announcement | +0.63% | SEC filing | |
| Executive or board change · Other company news | +2.76% | SEC filing | |
| Bylaws or fiscal year change · Shareholder vote results | +2.76% | SEC filing | |
| Shareholder vote results · Other company news | −1.76% | SEC filing | |
| Other company news | −1.10% | SEC filing | |
| Other company news | +1.26% | SEC filing | |
| Other company news | −0.97% | SEC filing | |
| Other company news | −0.86% | SEC filing | |
| Other company news | +0.69% | SEC filing | |
| Executive or board change | +0.95% | SEC filing | |
| Other company news | −2.97% | SEC filing | |
| Results update · Investor presentation or announcement | +2.64% | SEC filing | |
| Signed a material agreement · New debt or financing | +1.73% | SEC filing | |
| Signed a material agreement | +0.52% | SEC filing | |
| Other company news | −4.57% | SEC filing | |
| Shareholder vote results | +0.32% | SEC filing | |
| Investor presentation or announcement | −0.85% | SEC filing | |
| Other company news | −0.38% | SEC filing | |
| Other company news | −0.17% | SEC filing | |
| Other company news | −0.51% | SEC filing | |
| Other company news | −0.62% | SEC filing | |
| Shareholder vote results | −1.40% | SEC filing | |
| Other company news | −0.56% | SEC filing | |
| Other company news | +0.85% | SEC filing | |
| Bylaws or fiscal year change | +0.32% | SEC filing | |
| Results update | +5.37% | SEC filing | |
| Other company news | +1.95% | SEC filing | |
| Other company news | +0.60% | SEC filing | |
| Completed an acquisition or sale of assets | −1.57% | SEC filing | |
| Other company news | +0.76% | SEC filing | |
| Signed a material agreement | +0.76% | SEC filing | |
| Investor presentation or announcement | +0.35% | SEC filing | |
| Signed a material agreement · Other company news | +0.25% | SEC filing | |
| Investor presentation or announcement | −0.43% | SEC filing | |
| Shareholder vote results | −0.17% | SEC filing | |
| Executive or board change | +0.59% | SEC filing | |
| Executive or board change | +0.39% | SEC filing | |
| Results update | +2.72% | SEC filing | |
| Other company news | +1.66% | SEC filing | |
| Bylaws or fiscal year change | −0.06% | SEC filing | |
| Other company news | −0.79% | SEC filing | |
| Other company news | +0.40% | SEC filing | |
| Other company news | −1.19% | SEC filing | |
| Shareholder vote results | +0.71% | SEC filing | |
| Investor presentation or announcement | −1.01% | SEC filing | |
| Bylaws or fiscal year change | −0.09% | SEC filing | |
| Results update | +4.31% | SEC filing | |
| Other company news | +0.22% | SEC filing | |
| Other company news | −0.38% | SEC filing | |
| Signed a material agreement | +0.30% | SEC filing | |
| Executive or board change | −1.03% | SEC filing | |
| Executive or board change | +0.67% | SEC filing | |
| Other company news | −0.53% | SEC filing | |
| Executive or board change | +1.87% | SEC filing | |
| Executive or board change · Bylaws or fiscal year change · Shareholder vote results | +0.90% | SEC filing | |
| Executive or board change | +0.34% | SEC filing | |
| Executive or board change | −0.84% | SEC filing | |
| Other company news | −0.68% | SEC filing | |
| Results update | +2.02% | SEC filing | |
| Other company news | +0.85% | SEC filing | |
| Other company news | +1.00% | SEC filing | |
| Other company news | −1.16% | SEC filing | |
| Signed a material agreement | +0.42% | SEC filing | |
| Other company news | +0.13% | SEC filing | |
| Bylaws or fiscal year change · Shareholder vote results | +0.44% | SEC filing | |
| Executive or board change | −1.34% | SEC filing | |
| Executive or board change | +0.31% | SEC filing | |
| Results update | +8.86% | SEC filing | |
| Other company news | −1.62% | SEC filing | |
| Other company news | +0.80% | SEC filing | |
| Signed a material agreement | +0.42% | SEC filing | |
| Other company news | +3.14% | SEC filing | |
| Change to shareholder rights · Other company news | +3.66% | SEC filing | |
| Other company news | −3.52% | SEC filing | |
| Bylaws or fiscal year change · Shareholder vote results | +0.58% | SEC filing | |
| Other company news | +1.84% | SEC filing | |
| Executive or board change | −0.09% | SEC filing | |
| Executive or board change | +1.25% | SEC filing | |
| Signed a material agreement | +0.06% | SEC filing | |
| Bylaws or fiscal year change | +0.43% | SEC filing | |
| Other company news | +1.38% | SEC filing | |
| Other company news | −1.87% | SEC filing | |
| Executive or board change · Bylaws or fiscal year change · Shareholder vote results | −1.97% | SEC filing | |
| Other company news | +0.16% | SEC filing | |
| Executive or board change | +3.73% | SEC filing | |
| Other company news | −20.14% | SEC filing | |
| Other company news | −0.38% | SEC filing | |
| Other company news | +1.57% | SEC filing | |
| Executive or board change | +6.37% | SEC filing | |
| Bylaws or fiscal year change | +0.72% | SEC filing | |
| Results update | −12.44% | SEC filing | |
| Bylaws or fiscal year change | +1.45% | SEC filing | |
| Other company news | +3.15% | SEC filing | |
| Other company news | +1.15% | SEC filing | |
| Other company news | −1.73% | SEC filing | |
| Signed a material agreement · Other company news | +0.16% | SEC filing | |
| Executive or board change | −0.27% | SEC filing | |
| Executive or board change | −0.74% | SEC filing | |
| Bylaws or fiscal year change | +2.11% | SEC filing | |
| Results update | −6.56% | SEC filing | |
| Executive or board change · Bylaws or fiscal year change · Other company news | +1.25% | SEC filing | |
| Signed a material agreement | −0.43% | SEC filing | |
| Results update | +3.53% | SEC filing | |
| Auditor change | +3.53% | SEC filing | |
| Other company news | +0.88% | SEC filing | |
| Executive or board change | 0.00% | SEC filing | |
| Other company news | −0.27% | SEC filing | |
| Signed a material agreement | +2.06% | SEC filing | |
| Signed a material agreement | −0.16% | SEC filing | |
| Other company news | −0.16% | SEC filing | |
| Bylaws or fiscal year change · Other company news | −1.45% | SEC filing | |
| Completed an acquisition or sale of assets · Executive or board change · Bylaws or fiscal year change | +0.76% | SEC filing | |
| Other company news | +0.59% | SEC filing | |
| Other company news | −0.31% | SEC filing | |
| Other company news | +1.96% | SEC filing | |
| Bylaws or fiscal year change | +0.33% | SEC filing | |
| Other company news | −0.75% | SEC filing | |
| Other company news | +2.05% | SEC filing | |
| Signed a material agreement | +3.38% | SEC filing | |
| Executive or board change | −0.24% | SEC filing | |
| Signed a material agreement · Other company news | −0.24% | SEC filing | |
| Results update | 0.00% | SEC filing | |
| Executive or board change | +1.84% | SEC filing | |
| Signed a material agreement | −1.40% | SEC filing | |
| Executive or board change | −0.85% | SEC filing | |
| Investor presentation or announcement | −0.33% | SEC filing | |
| Completed an acquisition or sale of assets | +2.35% | SEC filing | |
| Executive or board change | −0.51% | SEC filing | |
| Signed a material agreement · Executive or board change | −0.80% | SEC filing | |
| Signed a material agreement | +1.48% | SEC filing | |
| Investor presentation or announcement | +0.04% | SEC filing | |
| Investor presentation or announcement | −1.63% | SEC filing | |
| Results update | −6.24% | SEC filing | |
| Bylaws or fiscal year change | +3.96% | SEC filing | |
| Signed a material agreement | −0.38% | SEC filing | |
| Results update · Other company news | +0.93% | SEC filing | |
| Signed a material agreement | −0.29% | SEC filing | |
| Signed a material agreement | −0.08% | SEC filing | |
| Signed a material agreement · New debt or financing | +1.44% | SEC filing | |
| Executive or board change | −1.90% | SEC filing | |
| Other company news | +0.25% | SEC filing | |
| Investor presentation or announcement | +0.35% | SEC filing |
CVS price history and multi-year cycles
Daily percent change, June 1, 1972 to November 13, 2026
Close is plotted by default. Add open, high, low or volume from the legend, and drag across the chart to zoom into any period.
Stock market cycle · 53 complete years, monthly closes since Jun 1972
Some sign of a multi-year rhythm. The strongest repeating swing around CVS's long-term trend lasts about 7.3 years from peak to peak, moving the price roughly ±18% around the trend and explaining 27% of the swings. Random price wandering with the same persistence produces a cycle at least that strong in ~2% of simulations, so it is unlikely to be pure chance.
Using swings of 23% or more (scaled to its volatility of 29% a year), CVS made 19 major peaks and 19 major troughs. Peaks came every 2.3 years (median; range 0.8–6.2), troughs every 2.5 years. The spacing is irregular, so the gaps are not a reliable clock. Typical drawdown: −34% over 10 months; typical recovery to the next peak: 14 months.
Latest major turning point: a trough in Dec 2024, 23 months ago; the price has moved +99% since and is −21% from its all-time high. If the 7.3-year rhythm held, the fitted cycle last peaked around Dec 2021 and would next bottom around Dec 2032 and peak around Apr 2029. Treat this as a description of the past, not a forecast: cycles found in prices often fade or shift.
10 of its 19 major drawdowns overlapped a broad S&P 500 sell-off or bear market (within three months), a mix of market-wide and company-specific falls. Its swings around trend move partly with the Dow's (correlation 0.57 over 55 years); the Dow's own strongest cycle is about 3.5 years. Calendar-year returns show no meaningful year-to-year memory: one year's result has said little about the next.
Since 2009, reported EPS was below the year-earlier quarter in 20 of 63 quarters. Earnings down-cycles of two or more quarters began in May 2016 (2 quarters, price −3%), Nov 2022 (3 quarters, price −19%), May 2024 (3 quarters, price −11%), Jul 2025 (2 quarters, price +29%). They started every 1.5 years (median).
Computed from monthly closes (not adjusted for dividends): trend = 10-year local regression of log price; cycle = best sine fit from 2 to 8 years, tested against 120 red-noise simulations; turning points use a volatility-scaled reversal threshold; EPS from SEC filings. Past cycles do not predict future prices; this is not investment advice.
CVS stock cycle: price vs long-term trend, with major peaks and troughs
The blue line is how far the monthly close sat above (+) or below (−) its 10-year trend; triangles mark the major turning points; grey bands are S&P 500 bear markets and crashes. The orange dashed line is the best-fitting repeating cycle; the dotted part only shows where that rhythm would point if it continued. Drag the panel below the chart to zoom.
| Term year | Years | Average return | Up years | Dow, same years |
|---|---|---|---|---|
| Post-election year | 14 | +12.8% | 10 of 14 | +10.2% |
| Midterm year | 13 | +8.8% | 6 of 13 | +2.2% |
| Pre-election year | 13 | +19.4% | 8 of 13 | +16.5% |
| Election year | 13 | +13.1% | 9 of 13 | +5.8% |
Show all 19 drawdowns and recoveries (peak to trough)
| Peak | Trough | Drawdown | Months down | Recovery to next peak | Months up | During S&P 500 sell-off |
|---|---|---|---|---|---|---|
| Jan 2022 | Dec 2024 | −58% | 35 | +99% (so far) | 23+ | Yes |
| Nov 2019 | Oct 2020 | −25% | 11 | +90% | 15 | Yes |
| Nov 2018 | May 2019 | −35% | 6 | +44% | 6 | Yes |
| Jul 2015 | Mar 2018 | −45% | 32 | +29% | 8 | No |
| Aug 2009 | Aug 2010 | −28% | 12 | +317% | 59 | No |
| May 2008 | Feb 2009 | −40% | 9 | +46% | 6 | Yes |
| Mar 2002 | Jan 2003 | −34% | 10 | +278% | 64 | Yes |
| Feb 2001 | Oct 2001 | −61% | 8 | +44% | 5 | Yes |
| Dec 1998 | Jan 2000 | −36% | 13 | +75% | 13 | Yes |
| May 1995 | Feb 1996 | −31% | 9 | +299% | 34 | No |
| Nov 1992 | Jan 1995 | −43% | 26 | +29% | 4 | No |
| May 1991 | Nov 1991 | −24% | 6 | +31% | 12 | No |
| Jul 1990 | Oct 1990 | −33% | 3 | +55% | 7 | Yes |
| Jul 1987 | Nov 1987 | −41% | 4 | +124% | 32 | Yes |
| May 1986 | Dec 1986 | −24% | 7 | +47% | 7 | No |
| Jun 1983 | May 1984 | −27% | 11 | +113% | 24 | No |
| Aug 1978 | Feb 1980 | −24% | 18 | +269% | 40 | No |
| Dec 1976 | May 1977 | −24% | 5 | +61% | 15 | No |
| Jun 1972 | Nov 1974 | −81% | 29 | +391% | 25 | Yes |
What if you had traded CVS by simple rules?
$10,000 in CVS · January 2008 to Nov 13, 2026
Trading hours vs overnight
More of CVS's gains came during trading hours: owning it only from open to close turned $10,000 into $19,806, owning it only from close to the next open into $11,361. Together they make up buy and hold ($22,706).
Did the seasonal signal help? Picked better days
Average open-to-close move: +0.062% on the 1,269 days when all three methods pointed up, +0.025% on all days, −0.058% on the 767 down-signal days. Holding from the previous close to the next open: +0.11% around up-signal days vs +0.04% on any day.
Hypothetical results from daily open and close prices since January 2008 (earlier prices are rounded too coarsely for open-based tests), price only: dividends are not added back, and because a stock drops by its dividend at the open on the ex-dividend date, overnight results of dividend payers are understated by roughly their dividend yield; no taxes. The "after costs" column deducts 0.05% per trade; real spreads, commissions and slippage can be larger, which matters most for daily rules. Seasonal signals use only data from years before each trade. Past results do not predict future results. Study: these rules across 293 stocks and ETFs.
| Rule | $10,000 became | Per year | Last 10 yrs, per year | Trades | Winning trades | Average trade | Worst drawdown | After 0.05% per trade |
|---|---|---|---|---|---|---|---|---|
| Open to close, every dayBuy at each open, sell at the same day's close (trading hours only) | $19,806 | +3.7% | −3.0% | 4,749 | 51% | +0.02% | −54% | $1,842 |
| Close to next open, every dayBuy at each close, sell at the next open (overnight only) | $11,361 | +0.7% | +4.8% | 4,748 | 52% | +0.01% | −51% | $1,057 |
| Open to next openBuy at the open, sell at the next session's open | $22,634 | +4.4% | +1.9% | 4,748 | 52% | +0.03% | −61% | $2,106 |
| Close to close (buy and hold)Buy at the close, sell at the next close: the same as holding | $22,706 | +4.4% | +1.6% | 4,748 | 51% | +0.03% | −61% | $2,113 |
| Each week, open to closeBuy the week's first open, sell its last close (out over weekends) | $25,443 | +5.1% | +1.9% | 985 | 55% | +0.16% | −59% | $15,546 |
| Each month, open to closeBuy the month's first open, sell its last close | $21,360 | +4.1% | +1.9% | 227 | 52% | +0.61% | −54% | $19,068 |
| Each year, open to closeBuy the year's first open, sell its last close | $19,547 | +3.6% | +0.0% | 18 | 56% | +7.58% | −56% | $19,372 |
| Up-signal days, open to closeOn each day when all three seasonal methods point up: buy at that day's open, sell at its close. Otherwise in cash. | $19,227 | +3.5% | +5.1% | 1,269 | 52% | +0.06% | −25% | $10,192 |
| Up-signal days, close before to open afterBuy at the close the day before an up-signal day, sell at the open the day after it. Back-to-back signal days are held as one trade. | $31,786 | +6.3% | +11.0% | 823 | 54% | +0.17% | −35% | $21,061 |
| Hold, but sit out down-signal daysHold all the time, except: sell at the close before a day when all three methods point down, stay in cash through that day (and any down days right after it), buy back at the close of the last one. | $40,356 | +7.7% | +6.0% | 617 | 55% | +0.31% | −53% | $29,641 |
Growth of $10,000 under each rule (log scale)
Each line is the value of $10,000 following one rule from January 2008. On a log scale, equal slopes mean equal percentage growth. Click the legend to add the weekly, monthly and other seasonal rules.
| Day type | Days | Open to close | Up days | Previous close to next open | Up |
|---|---|---|---|---|---|
| All three methods up | 1,269 | +0.062% | 52% | +0.11% | 53% |
| All three methods down | 767 | −0.058% | 49% | −0.05% | 51% |
| All days | 4,749 | +0.025% | 51% | +0.04% | 52% |
CVS seasonality data tables
Updated This CVS seasonality chart is built from 13,734 trading days of historical data, spanning from through — covering 55 years of market activity.
Sessions traded per month for CVS. Months with more sessions carry more weight in every seasonal average below.
Year-by-year performance for CVS Health Corporation, so a seasonal pattern can be read against the trend it sits inside.
How to read this CVS seasonality page
CVS seasonality FAQ
What is the best month for CVS stock?
Historically March: across 53 complete years (1973–2025) CVS averaged +3.3% in March and finished the month higher in 34 of 53 years. Its weakest month has been October (average −1.1%, higher in 25 of 53 years).
How has CVS performed in the next four weeks historically?
In the 20 trading sessions after November 13, CVS rose in 26 of 53 past years, with an average move of −0.5% and a median of 0.0%. This is a historical record, not a forecast.
What is CVS seasonality?
Seasonality is the tendency of a stock or fund to behave differently at particular points of the calendar. This page measures it for CVS Health Corporation three ways (by calendar date, by week and weekday, and by trading day of the month) across 13,734 trading sessions.
How are the seasonal averages calculated?
From daily closing prices, compounded rather than added, so a 10% gain followed by a 10% loss counts as the 1% loss it really is. Each year's year-to-date return is carried over weekends and holidays, and only complete calendar years enter the averages. Prices are adjusted for splits but not for dividends.
Why do the three seasonality methods sometimes disagree?
They line the data up differently. A calendar date falls on a different weekday and a different trading day of the month every year, so an effect driven by month-end flows shows clearly by trading day and only faintly by date. Agreement across all three is the stronger signal.
How current is the data?
Prices are refreshed automatically after each trading session and checked for gaps, duplicates, bad prints and unadjusted splits. The latest session on file is November 13, 2026.
Can seasonality be traded on its own?
No. These are historical averages over a limited number of years, and any single year can differ completely. Treat a seasonal pattern as context for a decision you have other reasons to make, and read the disclaimer.
Full method: how SeasonalityCharts measures seasonality · Disclaimer
Data last refreshed November 13, 2026. Seasonality figures are historical averages drawn from 13,734 trading sessions; they are not a forecast, and nothing on this page is investment advice. Please do your own research and see the Disclaimer.
